Long-term outcomes are good in the majority of young children with refractory febrile status epilepticus (SE), according to new research presented at AES 2018.
Specialists from the University of Texas Southwestern Medical Center, in Dallas, Texas, USA, performed a single-center retrospective observational study, identifying all patients aged between 1 month and 5 years who were admitted to the pediatric ICU with refractory febrile SE in the period 2008-2017.
The condition was defined as SE where the only acute provocation was fever, which persisted despite the administration of at least two parenteral antiepileptic medications, including a benzodiazepine.
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.